BCL2L14 and inflammatory bowel disease: Collectively, our data highlight transcript-specific differences in BCL-G expression in human gastrointestinal disease, with BCL-GS repression detected in active IBD and downregulation of both BCL-G transcripts observed in colorectal cancer.